73 related articles for article (PubMed ID: 33999741)
1. The role of age and opioid agonist treatment on substance use treatment completion in the United States.
van den Berk Clark C; Pickard JG; Drallmeier T
Aging Ment Health; 2022 Jun; 26(6):1295-1302. PubMed ID: 33999741
[TBL] [Abstract][Full Text] [Related]
2. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities.
Pickard JG; van den Berk-Clark C; Matthieu MM
Mil Med; 2022 Mar; 187(3-4):504-512. PubMed ID: 34173832
[TBL] [Abstract][Full Text] [Related]
3. Are Rural Opioid Treatment Program (OTP) Facilities Associated with Lower Deaths?
Meadowcroft D; Whitacre B
Subst Use Misuse; 2020; 55(5):828-838. PubMed ID: 31856628
[No Abstract] [Full Text] [Related]
4. Comprehensive analysis of discharge reasons from methadone outpatient treatment programs.
Andraka-Christou B; Totaram R; Nguyen TD
Am J Addict; 2022 Nov; 31(6):508-516. PubMed ID: 35996855
[TBL] [Abstract][Full Text] [Related]
5. Readmissions Following Inpatient Treatment for Opioid-Related Conditions.
Blanchard J; Weiss AJ; Barrett ML; Stocks C; Owens PL; Coffey R; Heslin KC
Subst Use Misuse; 2019; 54(3):473-481. PubMed ID: 30618327
[TBL] [Abstract][Full Text] [Related]
6. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
Day E; Strang J
J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
[TBL] [Abstract][Full Text] [Related]
7. State-level regulations and opioid-related health outcomes.
Jackson JR; Harle CA; Silverman R; Simon K; Menachemi N
Drug Alcohol Depend; 2022 Mar; 232():109294. PubMed ID: 35066461
[TBL] [Abstract][Full Text] [Related]
8. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
[TBL] [Abstract][Full Text] [Related]
9. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care.
Faiz J; Bernstein E; Dugas JN; Schechter-Perkins EM; Nentwich L; Nelson KP; Cleveland Manchanda EC; Young L; Pare JR
Am J Emerg Med; 2022 Apr; 54():221-227. PubMed ID: 35180668
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
11. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.
Laks J; Kehoe J; Farrell NM; Komaromy M; Kolodziej J; Walley AY; Taylor JL
Addict Sci Clin Pract; 2021 Dec; 16(1):73. PubMed ID: 34961554
[TBL] [Abstract][Full Text] [Related]
12. Characterizing variability in state-level regulations governing opioid treatment programs.
Jackson JR; Harle CA; Silverman RD; Simon K; Menachemi N
J Subst Abuse Treat; 2020 Aug; 115():108008. PubMed ID: 32600617
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India.
Ghosh A; Sharma N; Noble D; Basu D; Mattoo SK; Nanjayaya SB; Pillai RR; Kaur S
J Addict Med; 2023 Mar-Apr 01; 17(2):e101-e109. PubMed ID: 36149004
[TBL] [Abstract][Full Text] [Related]
14. Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.
Frimpong JA; D'Aunno T; Helleringer S; Metsch LR
J Subst Abuse Treat; 2016 Apr; 63():46-53. PubMed ID: 26810130
[TBL] [Abstract][Full Text] [Related]
15. Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs.
Cleland CM; Rosenblum A; Fong C; Maxwell C
Subst Abuse Treat Prev Policy; 2011 Jun; 6():11. PubMed ID: 21635762
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Regular Versus After Hours Admissions to a 24-hour Opioid Treatment Program.
Sherrick RC
J Addict Med; 2023 May-Jun 01; 17(3):e206-e208. PubMed ID: 37267190
[TBL] [Abstract][Full Text] [Related]
17. HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations.
D'Aunno T; Pollack HA; Jiang L; Metsch LR; Friedmann PD
Health Serv Res; 2014 Feb; 49(1):230-48. PubMed ID: 23855724
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with counselling adherence in opioid treatment programs.
Placide V; Unruh L; Atkins D; Chisholm L; Scott JB
Health Soc Care Community; 2022 Nov; 30(6):e6303-e6311. PubMed ID: 36250340
[TBL] [Abstract][Full Text] [Related]
19. The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex.
Stenersen MR; Thomas K; Struble C; Moore KE; Burke C; McKee S
J Subst Abuse Treat; 2022 May; 136():108662. PubMed ID: 34840040
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
